Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer vaccine
Biotech
OSE turns up the heat on ovarian cancer with phase 2 win
Researchers linked maintenance use of the neo-epitope vaccine candidate and Keytruda to improvements over best supportive care.
Nick Paul Taylor
May 22, 2026 7:14am
After FDA refusal, IO Biotech surrenders to bankruptcy
Mar 31, 2026 10:17am
IO mulls more layoffs months after halving head count
Jan 21, 2026 7:20am
Merck, Moderna sustain 49% melanoma risk reduction at 5 years
Jan 20, 2026 8:50am
Moderna cancer push 'makes sense' when HHS skeptical of vaccines
Oct 22, 2025 3:00am
BioNTech fades cancer vax in late-stage melanoma setting
Oct 20, 2025 3:01pm
